Literature DB >> 3130586

Progressive myoclonus epilepsy treated with zonisamide.

T R Henry1, I E Leppik, R J Gumnit, M Jacobs.   

Abstract

Two patients with progressive myoclonus epilepsy of the Unverricht-Lundborg type and with intractable seizures in spite of standard anticonvulsant regimens were treated with zonisamide. After zonisamide therapy was initiated, both had a marked decrease in seizure frequency and significant improvement of functioning. Serum zonisamide concentrations were 43 and 27 micrograms/ml, respectively, with doses of 8.8 and 10.5 mg/kg/d. Both patients also continue to receive valproic acid and a benzodiazepine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3130586     DOI: 10.1212/wnl.38.6.928

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  Drug Treatment of Progressive Myoclonic Epilepsy.

Authors:  Gregory L Holmes
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

2.  Progressive Myoclonic Epilepsies.

Authors:  Basim M. Uthman; Andreas Reichl
Journal:  Curr Treat Options Neurol       Date:  2002-01       Impact factor: 3.598

Review 3.  Advances in our understanding of early childhood epilepsies: 1999-2000.

Authors:  D R Nordli; E Wyllie; K D Holland
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

4.  Non-convulsive Status Epilepticus in SEMA6B-Related Progressive Myoclonic Epilepsy: A Case Report With Literature Review.

Authors:  Jing Duan; Yan Chen; Zhanqi Hu; Yuanzhen Ye; Tian Zhang; Cong Li; Qi Zeng; Xia Zhao; Jiahui Mai; Yang Sun; Chao Liu; Wenxin Zheng; Yuhan Xiao; Jianxiang Liao; Li Chen
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.569

Review 5.  Newer antiepileptic drugs. Towards an improved risk-benefit ratio.

Authors:  P N Patsalos; J W Sander
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

6.  Zonisamide - a review of experience and use in partial seizures.

Authors:  Angus A Wilfong; L James Willmore
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

7.  Zonisamide-responsive myoclonus in SEMA6B-associated progressive myoclonic epilepsy.

Authors:  Rebecca Herzog; Yorck Hellenbroich; Norbert Brüggemann; Katja Lohmann; Mona Grimmel; Tobias B Haack; Sarah von Spiczak; Alexander Münchau
Journal:  Ann Clin Transl Neurol       Date:  2021-06-06       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.